Medizinische Universität Graz - Research portal
Ritter Cathrin |
** = Publications listed in SCI/SSCI/Pubmed
2021
Full paper/article (Journal)
** Fan, K; Spassova, I; Gravemeyer, J; Ritter, C; Horny, K; Lange, A; Gambichler, T; Ødum, N; Schrama, D; Schadendorf, D; Ugurel, S; Becker, JC
Merkel cell carcinoma-derived exosome-shuttle miR-375 induces fibroblast polarization by inhibition of RBPJ and p53.
Oncogene. 2021; 40(5):980-996
Doi: 10.1038/s41388-020-01576-6
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2020
Full paper/article (Journal)
** Fan, K; Gravemeyer, J; Ritter, C; Rasheed, K; Gambichler, T; Moens, U; Shuda, M; Schrama, D; Becker, JC
MCPyV Large T Antigen-Induced Atonal Homolog 1 Is a Lineage-Dependency Oncogene in Merkel Cell Carcinoma.
J Invest Dermatol. 2020; 140(1):56-65
Doi: 10.1016/j.jid.2019.06.135
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2018
Full paper/article (Journal)
** Fan, K; Ritter, C; Nghiem, P; Blom, A; Verhaegen, ME; Dlugosz, A; Ødum, N; Woetmann, A; Tothill, RW; Hicks, RJ; Sand, M; Schrama, D; Schadendorf, D; Ugurel, S; Becker, JC
Circulating Cell-Free miR-375 as Surrogate Marker of Tumor Burden in Merkel Cell Carcinoma.
Clin Cancer Res. 2018; 24(23):5873-5882
Doi: 10.1158/1078-0432.CCR-18-1184
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2017
Full paper/article (Journal)
** Ofner, R; Ritter, C; Heidenreich, B; Kumar, R; Ugurel, S; Schrama, D; Becker, JC
Distribution of TERT promoter mutations in primary and metastatic melanomas in Austrian patients.
J Cancer Res Clin Oncol. 2017; 143(4):613-617
Doi: 10.1007/s00432-016-2322-1
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Ofner, R; Ritter, C; Ugurel, S; Cerroni, L; Stiller, M; Bogenrieder, T; Solca, F; Schrama, D; Becker, JC
Non-reproducible sequence artifacts in FFPE tissue: an experience report.
J Cancer Res Clin Oncol. 2017; 143(7):1199-1207
Doi: 10.1007/s00432-017-2399-1
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Ritter, C; Fan, K; Paschen, A; Reker Hardrup, S; Ferrone, S; Nghiem, P; Ugurel, S; Schrama, D; Becker, JC
Epigenetic priming restores the HLA class-I antigen processing machinery expression in Merkel cell carcinoma.
Sci Rep. 2017; 7(1):2290-2290
Doi: 10.1038/s41598-017-02608-0
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Abstract (Journal)
** Ritter, C; Spassova, I; Fan, K; Herold, T; Boukamp, P; Becker, JC;
Variant MCC cell lines are more closely related to SCC than to classical MCC cell lines.
EXP DERMATOL. .. 2017; 26(3):E82-E83.-44th Annual Meeting of the Arbeitsgemeinschaft-Dermatologische-Forschung (ADF); MAR 09-11, 2017; Gottingen, GERMANY.
[Poster]
Web of Science
2016
Full paper/article (Journal)
** Ritter, C; Fan, K; Paulson, KG; Nghiem, P; Schrama, D; Becker, JC
Reversal of epigenetic silencing of MHC class I chain-related protein A and B improves immune recognition of Merkel cell carcinoma.
Sci Rep. 2016; 6:21678-21678
Doi: 10.1038/srep21678
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2014
Abstract (Journal)
** Fan, K; Ritter, C; Theiler, A; Houben, R; Schrama, D; Becker, JC
Ectopic expression and secretion of miR-375 in MCC: Impact on the tumor microenvironment
J DTSCH DERMATOL GES. . 2014; 12: 8-9.
[Poster]
Web of Science
** Ritter, C; Schrama, D; Houben, R; Becker, JC
Enhanced MHC class I molecule expression on Merkel cell carcinoma by HDAC inhibitors
J DTSCH DERMATOL GES. . 2014; 12: 8-8.
[Poster]
Web of Science
2013
Abstract (Journal)
** Ritter, C; Becker, JC; Schrama, D;
Reversible epigenetic silencing of NKG2D ligands MICA and MICB in Merkel cell carcinoma.
EXP DERMATOL. 2013; 22(3):E42-E42.-40th Annual Meeting of the Association-of-Dermatological-Research; MAR 14-16, 2013; Dessau, GERMANY.
[Oral Communication]
Web of Science
** Ritter, C; Schrama, D; Becker, JC;
Reinduction of epigenetically silenced NKG2D ligands MICA and MICB in Merkel cell carcinoma.
J DTSCH DERMATOL GES. 2013; 11(9):907-907.-ADO-Tagung; September, 2013; Essen, D.
[Oral Communication]
Web of Science
** Schrama, D; Ritter, C; Becker, J;
PDGFR alpha and Merkel Cell Carcinoma: pS478P Polymorphism and PDGFR-Inhibitors.
J DTSCH DERMATOL GES. 2013; 11(9):945-946.-ADO-Tagung; September, 2013; Essen, D.
[Oral Communication]
Web of Science
2012
Full paper/article (Journal)
** Hafner, C; Houben, R; Baeurle, A; Ritter, C; Schrama, D; Landthaler, M; Becker, JC
Activation of the PI3K/AKT pathway in Merkel cell carcinoma.
PLoS One. 2012; 7(2):e31255-e31255
Doi: 10.1371/journal.pone.0031255
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG